newsfilter
← Latest News
ACCESS Newswire·

XPhyto Reports Product Developments on Platform-Based Rotigotine Transdermal Patch for Parkinson's Disease

VANCOUVER, BC, AND UTTENWEILER, GERMANY / ACCESSWIRE / May 9, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a product development report on its Rotigotine transdermal ("TDS") patch, in